Literature DB >> 6174453

Metabolic and synthetic activities of Pneumocystis carinii in vitro.

E L Pesanti, C Cox.   

Abstract

Pneumocystic carinii organisms obtained from the lungs of rats with glucocorticoid-induced pneumocystosis retained a number of metabolic activities during in vitro culture for 48 to 72 h. They were able to metabolize [14C]glucose to 14CO2, to synthesize proteins from 3H-amino acids, and to synthesize ribonucleic acid from [3H]uridine. Utilization of [14C]glucose was inhibitable by excess unlabeled glucose, mannose, fructose, 2-deoxy-D-glucose, iodoacetate, and pentamidine, but not glycerol or trimethoprim-sulfamethoxazole. Protein synthesis was almost completely inhibited by incubation with high concentrations of cycloheximide, pentamidine, suramin, and chloroquine, but not by rifampin, tetracycline, or gentamicin. In additional experiments, P. carinii organisms that had been incubated overnight in the presence of potentially lethal agents were tested for their ability to utilize [14C]glucose in inhibitor-free medium as a test of viability. Pentamidine, at concentrations which caused only modest inhibition of glucose metabolism, protein synthesis, amino acid transport, or ribonucleic acid synthesis, was lethal, whereas trimethoprim-sulfamethoxazole was not.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174453      PMCID: PMC350955          DOI: 10.1128/iai.34.3.908-914.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Uptake and degradation of Pneumocystis carinii by macrophages in vitro.

Authors:  L A Von Behren; E L Pesanti
Journal:  Am Rev Respir Dis       Date:  1978-12

2.  Pentamidine: clinical pharmacologic correlations in man and mice.

Authors:  T P Waalkes; C Denham; V T DeVita
Journal:  Clin Pharmacol Ther       Date:  1970 Jul-Aug       Impact factor: 6.875

3.  Some effects of pentamidine di-isethionate on Crithidia fasciculata.

Authors:  W E Gutteridge
Journal:  J Protozool       Date:  1969-05

4.  Propagation of Pneumocystis carinii in vitro.

Authors:  L L Pifer; W T Hughes; M J Murphy
Journal:  Pediatr Res       Date:  1977-04       Impact factor: 3.756

5.  Serial propagation of Pneumocystis carinii in cell line cultures.

Authors:  C R Latorre; A J Sulzer; L G Norman
Journal:  Appl Environ Microbiol       Date:  1977-05       Impact factor: 4.792

6.  Studies of morphology and immunofluorescence of Pneumocystis carinii.

Authors:  H K Kim; W T Hughes; S Feldman
Journal:  Proc Soc Exp Biol Med       Date:  1972-10

7.  Catabolism of glucose and fatty acids by virulent Treponema pallidum.

Authors:  N L Schiller; C D Cox
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Direct fluorescent-antibody method for the diagnosis of Pneumocystis carinii pneumonitis from sputa or tracheal aspirates from humans.

Authors:  S K Lim; W C Eveland; R J Porter
Journal:  Appl Microbiol       Date:  1974-01

9.  Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage.

Authors:  E L Pesanti; S G Axline
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

10.  The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

Authors:  H Masur; T C Jones
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  19 in total

1.  Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro.

Authors:  D Boillot; P in't Veld; P Sai; G Feutren; W Gepts; R Assan
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

2.  Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.

Authors:  C J Boylan; W L Current
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Pneumocystis carinii: oxygen uptake, antioxidant enzymes, and susceptibility to oxygen-mediated damage.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

Review 4.  Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia.

Authors:  K L Goa; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

5.  Development and characterization of a rapid screening assay for identifying antipneumocystis agents.

Authors:  A Martinez; J A Kovacs
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

6.  Histoenzymological study of selected dehydrogenase enzymes in Pneumocystis carinii.

Authors:  M A Mazer; J A Kovacs; J C Swan; J E Parrillo; H Masur
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; C K Kim; J Foy; M J Linke; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

8.  Microculture screening assay for primary in vitro evaluation of drugs against Pneumocystis carinii.

Authors:  J C Comley; R J Mullin; L A Wolfe; M H Hanlon; R Ferone
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

9.  Pentamidine, a new diabetogenic drug in laboratory rodents.

Authors:  P Saï; D Boillot; C Boitard; M Debray-Sachs; G Reach; R Assan
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

10.  Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture.

Authors:  L L Pifer; D D Pifer; D R Woods
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.